Funded Tech Companies
Amunix Pharmaceuticals
Wondering who provided funding to Amunix Pharmaceuticals? BlackRock, Polaris Partners and Avidity Partners joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Amunix Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2 Tower Pl. 1100
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
At Amunix, we are focused on developing prodrugs to bring the promise of potent immune-activating biotherapeutics to patients with solid tumor cancers. We are leveraging our proprietary T cell engager (XPAT) and cytokine (XPAC) platforms to advance novel prodrugs that overcome the toxicity and immunogenicity challenges common to these therapeutic modalities.
Last Transaction
3/5/2021
Financing History
Management Team
Title
Name
Email & Social
Company Investors
- BlackRock
- Polaris Partners
- Avidity Partners
- Omega Funds (Otello Stampacchia)
- Frazier Healthcare Partners (James Brush)
- Venrock
- Longitude Capital Management (David Hirsch)
- Bain Capital Life Sciences
- CaaS Capital Management
- Casdin Capital
- Viking Global Investors
- Clough Capital Partners
- Redmile Group
- Janus Henderson Investors
- ArrowMark Partners
- Franklin Templeton
- Delian Capital
- Two River
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs